Commission facilitates faster access to medicines with clear rules for joint clinical assessments
The European Commission adopted new rules for the joint clinical assessments of medicines at Union level, contributing to faster access to medicines for EU patients. These new rules define the timelines and the steps for conducting EU joint clinical assessments.
Read the news announcement published by EC Directorate-General for Health and Food Safety on 23 May 2024.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (5 juillet 2024). Commission facilitates faster access to medicines with clear rules for joint clinical assessments. ELSIBI. Consulté le 10 décembre 2024 à l’adresse https://doi.org/10.58079/11y6d
